WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical achieved profitability on an Adjusted EBITDA basis for the third quarter 2025.
WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Mr. Brown has built a distinguished career leading complex manufacturing and supply chain organizations.
WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Come visit Rockwell Medical in Booth #316 at ASN Kidney Week 2025 in Houston, TX.
WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Our team's hard work and dedication are what make Rockwell Medical a leader in our industry and an exceptional place to build a career.
WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical will release its results for the third quarter ended September 30, 2025 on Wednesday, November 12, 2025.
WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Heather Hunter was promoted to Chief Operating Officer, having previously served as Chief Corporate Affairs Officer since August 2022.
Rockwell Medical (RMTI) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Rockwell Medical (RMTI) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stock
Rockwell Medical (RMTI) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are sti
Rockwell Medical, Inc. (NASDAQ:RMTI ) Q2 2025 Earnings Conference Call August 14, 2025 8:00 AM ET Company Participants Heather H. Hunter - Senior VP & Chief Corporate Affairs Officer Jesse Neri - Seni
Rockwell Medical (RMTI) came out with a quarterly loss of $0.05 per share in line with the Zacks Consensus Estimate. This compares to earnings of $0.01 per share a year ago.
WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical announces financial and operational results for the three and six months ended June 30, 2025.
WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical will release its results for the second quarter ended June 30, 2025 on Thursday, August 14, 2025.
WIXOM, Mich. & FRANKLIN, Tenn.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical will supply Innovative Renal Care with high-quality hemodialysis products to streamline workflows and
Rockwell Medical, Inc. (NASDAQ:RMTI ) Q1 2025 Earnings Conference Call May 12, 2025 8:00 AM ET Company Participants Heather Hunter - SVP, Chief Corporate Affairs Officer Mark Strobeck - President & CE
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE